PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $59,000 | +118.5% | 1,000 | +150.0% | 0.03% | +100.0% |
| Q1 2018 | $27,000 | -44.9% | 400 | -20.0% | 0.02% | -44.4% |
| Q4 2017 | $49,000 | -18.3% | 500 | 0.0% | 0.03% | -25.0% |
| Q3 2017 | $60,000 | -31.0% | 500 | -50.0% | 0.04% | -33.3% |
| Q2 2017 | $87,000 | +55.4% | 1,000 | -33.3% | 0.05% | +58.8% |
| Q1 2017 | $56,000 | +273.3% | 1,500 | +200.0% | 0.03% | +277.8% |
| Q4 2016 | $15,000 | -72.2% | 500 | -37.5% | 0.01% | -75.0% |
| Q3 2016 | $54,000 | +20.0% | 800 | -46.7% | 0.04% | +9.1% |
| Q2 2016 | $45,000 | – | 1,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |